High bax expression modulates response to treatment and survival in AML.

High bax expression modulates response to treatment and survival in AML.

Opis bibliograficzny
Główni autorzy:	Truran, L, Kell, J, Nicholson, D, Harrison, G, Hoy, T, Burnett, A
Format:	Journal article
Wydane:	1999

Podobne zapisy

Bim, Bak, and Bax regulate osteoblast survival.
od: Liang, M, i wsp.
Wydane: (2008)

The importance of diagnostic cytogenetics in older patients with AML: Analysis of 922 patients entered into the MRC AML 11 trial.
od: Grimwade, D, i wsp.
Wydane: (1999)

Del(9q) AML: Clinical, cytological and cytogenetic characteristics and prognostic implications for patients entering the MRC AML trials.
od: Peniket, A, i wsp.
Wydane: (1999)

Impact of diagnostic cytogenetics on outcome in AML: Analysis of 1,613 patients entered into the UK MRC AML 10 trial.
od: Grimwade, D, i wsp.
Wydane: (1996)

Mechanisms of response and resistance to AML therapies
od: Stoilova, B, i wsp.
Wydane: (2020)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
od: Grimwade, D, i wsp.
Wydane: (2001)

Gene expression profiling in MDS and AML: potential and future avenues.
od: Theilgaard-Mönch, K, i wsp.
Wydane: (2011)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
od: Grimwade, D, i wsp.
Wydane: (1998)

The presence of a FLT3 mutation in AML adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: Analysis of 854 patients from the MRC AML 10 and 12 trials.
od: Kottaridis, P, i wsp.
Wydane: (2000)

Association between reproducible flow cytometric methodology for measuring multidrug resistance and remission rates in AML
od: Pallis, M, i wsp.
Wydane: (1998)

Del (9q) AML: clinical and cytological characteristics and prognostic implications.
od: Peniket, A, i wsp.
Wydane: (2005)

Molecular characterization of the chromosome 9q deletion in AML.
od: Side, L, i wsp.
Wydane: (2000)

Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials
od: Hills, R, i wsp.
Wydane: (2018)

A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom medical research council (MRC) AML10 trial.
od: Wheatley, K, i wsp.
Wydane: (1995)

Schiff base metal derivatives enhance the expression of HSP70 and suppress BAX proteins in prevention of acute gastric lesion
od: Golbabapour, S., i wsp.
Wydane: (2013)

Azacitidine prolongs overall survival in older patients with Acute Myeloid Leukemia (AML) with poor prognostic karyotypes
od: Doehner, H, i wsp.
Wydane: (2017)

Suppression Of Aml1/ETO Via siRNA Mediated Gene Knockdown And Its Effects On FOXO3 AND c-Myc Expression In Aml t (8,21) Cells
od: Ong, Si Min
Wydane: (2017)

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials.
od: Kottaridis, P, i wsp.
Wydane: (2001)

No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials
od: Gale, R, i wsp.
Wydane: (2018)

CYTOLOGICAL FEATURES WITH PROGNOSTIC-SIGNIFICANCE IN AML
od: Swirsky, D, i wsp.
Wydane: (1983)

The graft-versus-leukemia effect in AML
od: Sweeney, C, i wsp.
Wydane: (2019)

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
od: Burnett, A, i wsp.
Wydane: (2002)

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial.
od: Hoyle, C, i wsp.
Wydane: (1989)

Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.
od: Cohen, H, i wsp.
Wydane: (2004)

Terahertz phase slips in striped La2−xBaxCuO4
od: Fu, D, i wsp.
Wydane: (2022)

Overcoming immunosenescence: strategies to modulate DNA damage and senescence in immune cells and fibroblasts
od: Kell, L
Wydane: (2024)

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
od: Freeman, SD, i wsp.
Wydane: (2023)

AML-399 A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acute myeloid leukemia (AML)
od: Vyas, P, i wsp.
Wydane: (2022)

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
od: Bhatnagar, N, i wsp.
Wydane: (2016)

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML
od: Chan, L, i wsp.
Wydane: (2004)

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
od: Robinson, H, i wsp.
Wydane: (2003)

Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial.
od: Watson, M, i wsp.
Wydane: (1999)

ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia
od: Al-Obaidi, M, i wsp.
Wydane: (2002)

Xanthorrhizol Induces Apoptosis Via the Up-regulation of Bax and p53 in HeLa Cells
od: Ismail, Norzila, i wsp.
Wydane: (2005)

Xanthorrhizol Induces Apoptosis Via the Up-regulation of Bax and p53 in HeLa Cells
od: Ismail, Norzila, i wsp.
Wydane: (2005)

Stripe melting and photoinduced enhancement of superconductivity in La2-xBaxCuO4
od: Khanna, V
Wydane: (2021)

Involvement of mitochondria in acetaminophen-induced apoptosis and hepatic injury: roles of cytochrome c, Bax, Bid, and caspases.
od: El-Hassan, H, i wsp.
Wydane: (2003)

Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML
od: Islam, M., i wsp.
Wydane: (2017)

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
od: Chan, L, i wsp.
Wydane: (2005)

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial
od: Burnett, A, i wsp.
Wydane: (2018)